Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial. [electronic resource]
Producer: 20190808Description: 2149-2156 p. digitalISSN:- 1432-1335
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chlorambucil -- administration & dosage
- Female
- Humans
- Immunotherapy
- Killer Cells, Natural -- pathology
- Lymphocyte Count
- Lymphocytes, Tumor-Infiltrating -- drug effects
- Lymphoma, Follicular -- diagnosis
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Prednisone -- administration & dosage
- Prognosis
- Retrospective Studies
- Rituximab -- administration & dosage
- T-Lymphocytes -- drug effects
- Treatment Outcome
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.